Greenwich LifeSciences, Inc. (GLSI)

Exchange NASDAQ
8.85


Currency in USD (Disclaimer)
Volume:
Day's Range:

GLSI Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-24 Patel Snehal director, 10 percent owner, officer: CEO and CFO 2,712,886.0 P-Purchase A 6,465.0 9.13 59,025.45
2022-06-24 Patel Snehal director, 10 percent owner, officer: CEO and CFO 2,706,421.0 P-Purchase A 22,535.0 9.13 205,744.55
2022-06-22 Daugherty Frank Joseph director, officer: Chief Medical Officer 104,890.0 A-Award A 104,890.0 7.63 800,310.70
2022-06-22 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,073,731.0 A-Award A 25,008.0 7.63 190,811.04
2022-06-22 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,048,723.0 A-Award A 1,048,723.0 7.63 8,001,756.49
2022-06-22 Thompson Jaye officer: VP Clinical Reg Affairs 149,818.0 A-Award A 149,818.0 7.63 1,143,111.34
2022-06-22 Hallock Kenneth director 41,349.0 A-Award A 41,349.0 7.63 315,492.87
2022-06-22 McWilliams David director 61,984.0 A-Award A 61,984.0 7.63 472,937.92
2022-06-22 Rothe Eric director 41,349.0 A-Award A 41,349.0 7.63 315,492.87
2022-06-16 Patel Snehal director, 10 percent owner, officer: CEO and CFO 2,683,886.0 P-Purchase A 8,000.0 7.13 57,040.00
2022-06-14 Patel Snehal director, 10 percent owner, officer: CEO and CFO 2,675,886.0 P-Purchase A 12,000.0 7.91 94,920.00
2022-06-10 Patel Snehal director, 10 percent owner, officer: CEO and CFO 2,663,886.0 P-Purchase A 12,000.0 8.33 99,960.00
2022-06-09 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,243,453.0 P-Purchase A 4,500.0 10.90 49,050.00
2022-06-07 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,238,953.0 P-Purchase A 6,000.0 8.55 51,300.00
2022-06-03 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,232,953.0 P-Purchase A 9,250.0 8.35 77,237.50
2022-06-02 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,223,703.0 P-Purchase A 6,774.0 7.38 49,992.12
2022-04-25 Daugherty Frank Joseph director, officer: Chief Medical Officer 90,121.0 P-Purchase A 1,000.0 16.25 16,250.00
2022-04-21 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,216,929.0 P-Purchase A 6,000.0 16.09 96,540.00
2022-04-19 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,210,929.0 P-Purchase A 6,000.0 16.74 100,440.00
2022-04-19 Thompson Jaye officer: VP Clinical Reg Affairs 255,995.0 P-Purchase A 500.0 16.74 8,370.00
2022-02-11 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,204,929.0 P-Purchase A 5,500.0 19.80 108,900.00
2022-02-04 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,199,429.0 P-Purchase A 5,000.0 19.59 97,950.00
2022-01-31 Thompson Jaye officer: VP Clinical Reg Affairs 255,495.0 P-Purchase A 500.0 18.47 9,235.00
2022-01-21 Hallock Kenneth director 397,304.0 P-Purchase A 300.0 16.32 4,896.00
2022-01-21 Thompson Jaye officer: VP Clinical Reg Affairs 254,995.0 P-Purchase A 500.0 16.33 8,165.00
2022-01-18 Thompson Jaye officer: VP Clinical Reg. Affairs 254,495.0 P-Purchase A 500.0 18.87 9,435.00
2022-01-13 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,194,429.0 P-Purchase A 1,000.0 19.99 19,990.00
2022-01-13 Daugherty Frank Joseph director, officer: Chief Medical Officer 89,121.0 P-Purchase A 1,000.0 19.99 19,990.00
2022-01-13 Thompson Jaye officer: VP Clinical Reg. Affairs 253,995.0 P-Purchase A 1,000.0 19.99 19,990.00
2022-01-03 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,193,429.0 P-Purchase A 2,050.0 23.82 48,830.79
2021-12-14 Patel Snehal director, 10 percent owner, officer: CEO and CFO 1,191,379.0 P-Purchase A 1,840.0 27.17 49,992.43
2021-12-14 McWilliams David director 620,301.0 P-Purchase A 200.0 27.56 5,512.18
2021-12-14 Daugherty Frank Joseph director, officer: Chief Medical Officer 88,121.0 P-Purchase A 1,111.0 26.99 29,983.45
2021-04-13 Patel Snehal director, officer: CEO and CFO 1,189,539.0 P-Purchase A 2,700.0 36.98 99,852.75
2020-11-24 Hallock Kenneth director 397,004.0 P-Purchase A 1,000.0 5.39 5,386.00
2020-11-23 Daugherty Frank Joseph director, officer: Chief Medical Officer 87,010.0 P-Purchase A 1,000.0 5.10 5,100.00
2020-11-20 Rothe Eric director 313,226.0 P-Purchase A 2,000.0 5.40 10,800.00
2020-11-20 McWilliams David director 620,101.0 P-Purchase A 1,500.0 5.40 8,100.00
2020-11-20 Hallock Kenneth director 396,004.0 P-Purchase A 1,000.0 5.37 5,370.00
2020-11-19 Patel Snehal director, officer: CEO and CFO 1,186,839.0 P-Purchase A 2,000.0 0.00 0.00
2020-11-10 Patel Pankaj Amrit 10 percent owner 0.0 J-Other D 187,266.0 0.00 0.00
2020-09-29 Patel Kinnary 10 percent owner 0.0 M-Exempt D 76,780.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,184,839.0 P-Purchase A 16,667.0 4.60 76,709.87
2020-09-29 Patel Snehal director, officer: CEO and CFO 863,683.0 P-Purchase A 114,347.0 5.75 657,495.25
2020-09-29 Hallock Kenneth director 395,004.0 P-Purchase A 8,333.0 4.60 38,352.63
2020-09-29 Hallock Kenneth director 386,671.0 M-Exempt A 79,121.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,040,131.0 M-Exempt A 176,448.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 129,400.0 M-Exempt A 52,620.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 0.0 M-Exempt D 176,448.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,168,172.0 M-Exempt A 103,911.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,321,327.0 M-Exempt A 1,144,529.0 0.00 0.00
2020-09-29 Hallock Kenneth director 0.0 M-Exempt D 18,727.0 0.00 0.00
2020-09-29 Hallock Kenneth director 276,095.0 M-Exempt A 18,727.0 0.00 0.00
2020-09-29 Hallock Kenneth director 294,822.0 M-Exempt A 18,727.0 0.00 0.00
2020-09-29 Hallock Kenneth director 12,728.0 J-Other A 12,728.0 0.00 0.00
2020-09-29 Hallock Kenneth director 257,368.0 P-Purchase A 74,782.0 5.75 429,996.50
2020-09-29 McWilliams David director 446,979.0 P-Purchase A 2,608.0 5.75 14,996.00
2020-09-29 Patel Kinnary 10 percent owner 76,780.0 M-Exempt A 76,780.0 0.00 0.00
2020-09-29 Patel Kinnary 10 percent owner 7,292.0 J-Other A 7,292.0 0.00 0.00
2020-09-29 Patel Kinnary 10 percent owner 129,400.0 M-Exempt A 52,620.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 6,929.0 J-Other A 6,929.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 7,292.0 J-Other A 7,292.0 0.00 0.00
2020-09-29 Daugherty Frank Joseph director, officer: Chief Medical Officer 86,010.0 P-Purchase A 1,739.0 5.75 9,999.25
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,324,324.0 M-Exempt A 2,997.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,358,032.0 M-Exempt A 33,708.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,408,033.0 M-Exempt A 50,001.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 76,780.0 M-Exempt A 76,780.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 14,401.0 J-Other A 14,401.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,053,867.0 M-Exempt A 13,736.0 0.00 0.00
2020-09-29 Patel Snehal director, officer: CEO and CFO 1,064,261.0 M-Exempt A 10,394.0 0.00 0.00
2020-09-29 McWilliams David director 0.0 M-Exempt D 152,604.0 0.00 0.00
2020-09-29 McWilliams David director 599,583.0 M-Exempt A 152,604.0 0.00 0.00
2020-09-29 McWilliams David director 607,246.0 M-Exempt A 7,663.0 0.00 0.00
2020-09-29 McWilliams David director 610,992.0 M-Exempt A 3,746.0 0.00 0.00
2020-09-29 McWilliams David director 1,054.0 J-Other A 1,054.0 0.00 0.00
2020-09-29 McWilliams David director 618,601.0 M-Exempt A 7,609.0 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.